Single-Dose Brachytherapy for the Palliative Treatment of Esophageal Cancer

Brachytherapy (intraluminal radiotherapy) has been in use for more than two decades as a boost after external beam radiation for the definitive treatment of esophageal carcinoma. Recent studies have suggested that brachytherapy alone could be a promising therapy for the palliation of dysphagia caused by inoperable esophageal carcinoma. Single-dose brachytherapy has been shown to be not only more effective but also a safer palliative treatment for dysphagia than stent placement, which is currently the most widely used palliative treatment for esophageal cancer, and the wider use of brachytherapy in this setting is therefore warranted.

References

• 1 Parkin D M, Bray F I, Devesa S S. Cancer burden in the year 2000: the global picture.  Eur J Cancer. 2001;  37 (Suppl 8) 4-66
• 2 Botterweck A A, Schouten L J, Volovics A. et al . Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries.  Int J Epidemiol. 2000;  29 645-654
• 3 Devesa S S, Blot W J, Fraumeni J F Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States.  Cancer. 1998;  83 2049-2053
• 4 Pisani P, Parkin D M, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990.  Int J Cancer. 1999;  83 18-29
• 5 Sundelof M, Ye W, Dickman P W, Lagergren J. Improved survival in both histologic types of oesophageal cancer in Sweden.  Int J Cancer. 2002;  99 751-754
• 6 Medical Research Councel Oesophageal Cancer Working Group . Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial.  Lancet. 2002;  359 1727-1733
• 7 Malthaner R, Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer.  Cochrane Database Syst Rev. 2001;  4 CD001556
• 8 Geh J I. The use of chemoradiotherapy in oesophageal cancer.  Eur J Cancer. 2002;  38 300-313
• 9 Arnott S J, Duncan W, Gignoux M. et al . Preoperative radiotherapy for esophageal carcinoma.  Cochrane Database Syst Rev. 2000;  2 CD001799
• 10 Stuschke M, Stahl M, Wilke H. et al . Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the upper-thoracic and midthoracic esophagus.  Am J Clin Oncol. 2000;  23 233-238
• 11 Ohtsu A, Boku N, Muro K. et al . Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus.  J Clin Oncol. 1999;  17 2915-2921
• 12 Schraube P, Fritz P, Wannenmacher M F. Combined endoluminal and external irradiation of inoperable oesophageal carcinoma.  Radiother Oncol. 1997;  44 45-51
• 13 Taal B G, Aleman B M, Koning C C, Boot H. High dose rate brachytherapy before external beam irradiation in inoperable oesophageal cancer.  Br J Cancer. 1996;  74 1452-1457
• 14 Siersema P D, Hop W C, van Blankenstein M. et al . A comparison of three types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study.  Gastrointest Endosc. 2001;  54 145-153
• 15 Christie N A, Buenaventura P O, Fernando H C. et al . Results of expandable metal stents for malignant esophageal obstruction in 100 patients: short-term and long-term follow-up [and Discussion].  Ann Thorac Surg. 2001;  71 1797-1802
• 16 Kozarek R A, Raltz S, Brugge W R. et al . Prospective multicenter trial of esophageal Z-stent placement for malignant dysphagia and tracheoesophageal fistula.  Gastrointest Endosc. 1996;  44 562-567
• 17 Hishikawa Y, Kurisu K, Taniguchi M. et al . High-dose-rate intraluminal brachytherapy for esophageal cancer: 10 years experience in Hyogo College of Medicine.  Radiother Oncol. 1991;  21 107-114
• 18 Gaspar L E, Nag S, Herskovic A. et al . American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer. Clinical Research Committee, American Brachytherapy Society, Philadelphia, PA.  Int J Radiat Oncol Biol Phys. 1997;  38 127-132
• 19 Rowland C G, Pagliero K M. Intracavitary irradiation in palliation of carcinoma of oesophagus and cardia.  Lancet. 1985;  2 981-983
• 20 Brewster A E, Davidson S E, Makin W P. et al . Intraluminal brachytherapy using the high dose rate microSelectron in the palliation of carcinoma of the oesophagus.  Clin Oncol (R Coll Radiol). 1995;  7 102-105
• 21 Jager J, Langendijk H, Pannebakker M. et al . A single session of intraluminal brachytherapy in palliation of oesophageal cancer.  Radiother Oncol. 1995;  37 237-240
• 22 Kulhavy M, Sur R K, Levin C V. et al . Optimization of single-fraction high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer: a preliminary report.  Endocurie Hypertherm Oncol. 1995;  11 235-239
• 23 Sur R K, Donde B, Levin V C, Mannell A. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer.  Int J Radiat Oncol Biol Phys. 1998;  40 447-453
• 24 Sur R K, Levin C V, Donde B. et al . Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma: an International Atomic Energy Agency study.  Int J Radiat Oncol Biol Phys. 2002;  53 127-133
• 25 Sharma V, Mahantshetty U, Dinshaw K A. et al . Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy.  Int J Radiat Oncol Biol Phys. 2002;  52 310-315
• 26 Homs M Y, Eijkenboom W M, Coen V L. et al . High dose rate brachytherapy for the palliation of malignant dysphagia.  Radiother Oncol. 2003;  66 327-332
• 27 Homs M Y, Steyerberg E W, Eijkenboom W M. et al . Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial.  Lancet. 2004;  364 1497-1504
• 28 Nickers P, Kunkler I, Scalliet P. Modern brachytherapy: current state and future prospects.  Eur J Cancer. 1997;  33 1747-1751
• 29 Sur R, Donde B, Falkson C. et al . Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer.  Brachytherapy. 2004;  3 191-195
• 30 Sur R K, Kochhar R, Singh D P. Oral sucralfate in acute radiation oesophagitis.  Acta Oncol. 1994;  33 61-63
• 31 Morgan R A, Ellul J P, Denton E R. et al . Malignant esophageal fistulas and perforations: management with plastic-covered metallic endoprostheses.  Radiology. 1997;  204 527-532
• 32 Siersema P D, Schrauwen S L, van Blankenstein M. et al . Self-expanding metal stents for complicated and recurrent esophagogastric cancer.  Gastrointest Endosc. 2001;  54 579-586
• 33 Dumonceau J M, Cremer M, Lalmand B, Deviere J. Esophageal fistula sealing: choice of stent, practical management, and cost.  Gastrointest Endosc. 1999;  49 70-78
• 34 Homs M Y, Steyerberg E W, Eijkenboom W MH, Siersema P D. Predictors of outcome of single dose brachytherapy for the palliation of dysphagia from esophageal cancer. In press 2005.